Literature DB >> 29436796

Predictive Value of Braden Risk Factors in Pressure Ulcers of Outpatients With Spinal Cord Injury.

Fariba Sadeghi Fazel1, Nazi Derakhshanrad2, Mir Saeed Yekaninejad3, Fardis Vosoughi2, Asal Derakhshanrad2, Hooshang Saberi4.   

Abstract

Pressure Ulcers (PUs) remain among the most common complications after traumatic spinal cord Injuries (SCIs). The main goal of risk factor assessment with different tools has been to provisionally estimate the chance of developing pressure ulcers in patients with Spinal Cord Injury (SCI). Braden tool has been of good predictive value and most commonly employed in hospital communities for risk assessment of pressure sore development. The objective of this study was to determine the Braden risk factors as well as the prevalence of pressure injuries in SCI patients. This cross-sectional study was performed from June 2013 to December 2015 on 163 consecutive referred outpatients with chronic traumatic SCI in our tertiary SCI rehabilitation clinic. We assessed pressure induced skin injuries as well as their Braden risk factors and analyzed their association with stage and location of Pressure Ulcer (PU) and calculated prevalence of PU. One hundred and sixty-three patients out of 580 were found to have active pressure sores, with a prevalence of 28.1%. In the multiple models, only the Braden scale had significant association with the presence of active pressure sore. Patients with severe and moderate Braden scores were 2.36 and 1.82 times, more at risk of pressure sore development, as compared with those having mild scores (P≤0.01). It may be deduced that in various stages of SCI rehabilitation, the Braden scale may be calculated, and patients with moderate and severe risks (according to Braden sale) may need more attention and/or inpatient care for PU prevention.

Entities:  

Keywords:  Braden scalel; Pressure ulcer; Spinal cord injury

Mesh:

Year:  2018        PMID: 29436796

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  7 in total

1.  CD73 Promotes Glioblastoma Pathogenesis and Enhances Its Chemoresistance via A2B Adenosine Receptor Signaling.

Authors:  Angela Yan; Michelle L Joachims; Linda F Thompson; Andrew D Miller; Peter D Canoll; Margaret S Bynoe
Journal:  J Neurosci       Date:  2019-03-29       Impact factor: 6.167

2.  The effectiveness of pressure ulcer prevention programme: A comparative study.

Authors:  Abbas Al Mutair; Zainab Ambani; Fadillah Al Obaidan; Khulud Al Salman; Hashmiah Alhassan; Alya Al Mutairi
Journal:  Int Wound J       Date:  2019-11-06       Impact factor: 3.315

3.  The global burden of pressure ulcers among patients with spinal cord injury: a systematic review and meta-analysis.

Authors:  Wondimeneh Shibabaw Shiferaw; Tadesse Yirga Akalu; Henok Mulugeta; Yared Asmare Aynalem
Journal:  BMC Musculoskelet Disord       Date:  2020-05-29       Impact factor: 2.362

4.  Frequency and risk factors of pressure injuries in clinical settings of affiliated to Tabriz University of Medical Sciences.

Authors:  AhmadMirza Aghazadeh; Mojgan Lotfi; Hossein Asgarpour; Mohammad Khajehgoodari; Afsaneh Nobakht
Journal:  Nurs Open       Date:  2020-11-15

5.  Validation of the Helsinki University Hospital prevent pressure Injury Risk Assessment Tool: a prospective observational study.

Authors:  Anniina Heikkilä; Jaana Kotila; Kristiina Junttila
Journal:  BMC Nurs       Date:  2022-01-17

6.  Frequency of and risk factors for intensive care unit-acquired sacrum pressure injuries in critically ill patients: A multicenter cross-sectional study in China.

Authors:  Binqin Hu; Yang Zhao; Jijun Yang; Zhenhua Zeng; Yanhong Wu; Chunmei Gui; Jiang Gong; Yi Gao; Yong Yang; Cuizhu Luo; Yu Wang; Qingjuan Jiang; Wenlong Guo; Pan Lu; Fen Yuan; Xiaofang Li; Xingui Dai
Journal:  Health Sci Rep       Date:  2021-10-22

7.  Factors affecting the incidence and prevalence of pressure ulcers in COVID-19 patients admitted with a Braden scale below 14 in the intensive care unit: Retrospective cohort study.

Authors:  Mahin Amini; Feizollah Mansouri; Kamran Vafaee; Alireza Janbakhsh; Somayeh Mahdavikian; Yasaman Moradi; Masoud Fallahi
Journal:  Int Wound J       Date:  2022-03-23       Impact factor: 3.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.